PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: dental hygienist

Treating Hyperkalemia: Avoid Additional Harm When Using ...

Treating Hyperkalemia: Avoid Additional Harm When Using Insulin and Dextrose | Advisory Page 1 of 11. Pa Patient Saf Advis 2017 Sep;14(3). Treating Hyperkalemia: Avoid Additional Harm When Using Insulin and Dextrose Authors Staley Lawes, PharmD, BCPS, FISMP. Patient Safety Analyst Michael J. Gaunt, PharmD. Sr. Medication Safety Analyst Matthew Grissinger, RPh, FISMP, FASCP. Manager, Medication Safety Analysis Pennsylvania Patient Safety Authority Corresponding Author Matthew Grissinger Abstract Hyperkalemia is a fairly common, potentially life-threatening electrolyte disturbance encountered in hospitalized patients. Treatment of hyperkalemia with insulin and dextrose, without implementing clear protocols and error- reduction strategies, can lead to hypoglycemia and other patient harm.

by the pharmacy as Kayexalate® [sodium polystyrene sulfonate to treat high potassium levels] 30 g PO BID. No potassium level was returned on the patient until 0600 [the next day].

Fullscreen Download
Loading..

Tags:

  Sodium, Polystyrene, Sulfonate, Sodium polystyrene sulfonate

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of Treating Hyperkalemia: Avoid Additional Harm When Using ...

Documents from same domain

Opioid Knowledge Self-Assessment

patientsafety.pa.gov

Opioid Knowledge Self-Assessment Healthcare facilities can use this assessment for practitioners who prescribe, dispense, and/or administer opioid products ...

  Assessment, Opioid, Self, Knowledge, Opioid knowledge self assessment

Letter to the Editor: Preventing Air Embolism with PICC ...

patientsafety.pa.gov

letter to the editor: preventing air embolism with picc line removal I read with interest your article “Reducing Risk of Air Embolism Associated with Central Venous Access Devices” in the Pennsyl-

  With, Letter, Preventing, Editor, Letter to the editor, Ccpi, Embolism, Preventing air embolism with picc

Strategic Plan 2017-2020 - Patient Safety Authority

patientsafety.pa.gov

Strategic Plan During 2016, the Pennsylvania Patient Safety Authority Board of Directors and staff engaged in a third strate- ... Strategic Plan 2017–2020 VISION Safe healthcare for all patients MISSION Improve the quality of healthcare in Pennsylvania by collecting and

  2017, Strategic, Plan, 2200, Strategic plan, Strategic plan 2017 2020

PATIENT SAFETY: COLOR BANDING Standardization and ...

patientsafety.pa.gov

Color-banding policy will need to be reviewed and approved. Hospitals need to review their respective forms for need of modifications (pt. ed, assessments, etc.) ... • Color Code – Intent of Specific Colors • Authority for Application of band • Process for Band Confirmation • Inter-Dept./Agency Communication

  Policy, Code, Color, Color code

Confirming Feeding Tube Placement: Old Habits Die Hard

patientsafety.pa.gov

More Reliable Methods to Verify Feeding Tube Placement Radiographic Confirmation of Nasogastric Tube Placement The gold standard for nasogastric feeding tube placement is radiographic confirmation with a chest x-ray. pretations by nonradiologists: The gold standard for nasoenteric feeding tube placement is radiographic confir-

  Tubes, Placement, Nasogastric, Nasoenteric, Tube placement, Nasogastric tube placement

The Beers Criteria: Screening for Potentially ...

patientsafety.pa.gov

hepatic clearance of many drugs, such as diazepam, amitriptyline, and chlordiazepoxide, carried out by the cytochrome P-450 system often diminishes with age. Overall, the clearance of drugs metabolized by the liver is typically decreased 30 to 40% in the elderly. Renal size and renal blood flow also decrease signifi-cantly with age.

  Learn, Hepatic

Safety in Using Promethazine (Phenergan)

patientsafety.pa.gov

©2007 Pennsylvania Patient Safety Authority Page 1 Produced by ECRI Institute & ISMP under contract to the Patient Safety Authority Patient Safety Advisory F irst approved by the U.S. Food and Drug Ad-ministration (FDA) in 1951, promethazine (Phenergan) is a medication in common use today. However, despite its familiarity, its use is not with-

  Using, Safety, Phenergan, Promethazine, Is not, Safety in using promethazine

PATIENT SAFETY AUTHORITY AND DEPARTMENT OF HEALTH

patientsafety.pa.gov

12. A mid-procedure change in the plan of care in response to new information discovered during the procedure does not constitute an injury. 13. Additional healthcare services: a. Healthcare services provided to prevent an injury from occurring are excluded from this term for the purpose of Serious Event determinations. b.

  Safety, Procedures

Brochure Medical Records - Pennsylvania Patient Safety ...

patientsafety.pa.gov

record. In the future, when medi-cal records are requested by other providers, your provider must include his denial of your request to amend the medical record as well a copy of your statement of disagreement. It should not take more than 90 days to amend your medical records. If the request is accepted,

  Record, Medi, Cal records

Retained Surgical Items: Events and Guidelines Revisited

patientsafety.pa.gov

and the Association of periOperative Registered Nurses published guidance for preventing RSIs, including minimizing distractions and participating in team-work training. The Joint Commission speaks to the role of weak or absent organizational leadership as reasons for the continuance of RSIs. (Pa Patient Saf Advis 2017 Mar;14[1]:27-35.)

  Time, Nurse, Surgical, Association, Registered, Perioperative, Detainer, Association of perioperative registered nurses, Retained surgical items

Related documents

February 2010 (updated May 2015) ELDER CARE

nursingandhealth.asu.edu

phenolphthalein laxatives and/or sodium polystyrene sulfonate – can cause loss of potassium in the stool. It is important to question patients about laxative use because they may not report it unless asked.Magnesium deficiency Medications for COPD Sympathomimetic drugs, such as beta-adrenergic

  Sodium, Polystyrene, Sulfonate, Sodium polystyrene sulfonate

ポリスチレンスルホン酸Na「フソー」原末

pins.japic.or.jp

一般名：ポリスチレンスルホン酸ナトリウム（Sodium Polystyrene Sulfonate） 構造式：不規則に入り乱れた複雑な立体構造を有するが，次のような 一般構造式で示される。 性 状：黄褐色の粉末で，におい及び味はない。水，エタノール（95），

  Sodium, Polystyrene, Sulfonate, Sodium polystyrene sulfonate

Potassium Disorders: Hypokalemia and Hyperkalemia

www.aafp.org

Sep 15, 2015 · sodium polystyrene sulfonate is reserved for subacute treatment. For both disorders, it is important to consider poten - tial causes of transcellular shifts because patients are at increased risk ...

  Sodium, Polystyrene, Sulfonate, Sodium polystyrene sulfonate

Related search queries

Sodium polystyrene sulfonate